|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.24 CNY | -1.51% |
|
-2.22% | +19.48% |
| Jan. 09 | Xiamen Intretech's 2025 Profit to Soar Up to 162%; Shares Up 3% | MT |
| 25-10-30 | Xiamen Intretech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025 | CI |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.49 | 9 | 4.34 | 3.76 | 2.14 | |||||
Return on Total Capital | 15.27 | 11.68 | 5.31 | 4.48 | 2.56 | |||||
Return On Equity % | 23.46 | 21.07 | 12.74 | 8.99 | 5.26 | |||||
Return on Common Equity | 22.88 | 20.99 | 12.87 | 8.74 | 5.2 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 33.22 | 27.5 | 28.52 | 29.01 | 26.96 | |||||
SG&A Margin | 4.45 | 5.36 | 6.48 | 6.99 | 9.63 | |||||
EBITDA Margin % | 24.27 | 18.57 | 15.83 | 15.46 | 11.37 | |||||
EBITA Margin % | 22.44 | 16.31 | 12.91 | 11.94 | 7 | |||||
EBIT Margin % | 22.42 | 16.27 | 12.88 | 11.79 | 6.83 | |||||
Income From Continuing Operations Margin % | 20.11 | 15.94 | 16.3 | 12.46 | 7.47 | |||||
Net Income Margin % | 19.3 | 15.48 | 15.96 | 11.67 | 7.04 | |||||
Net Avail. For Common Margin % | 19.3 | 15.48 | 15.96 | 11.67 | 7.04 | |||||
Normalized Net Income Margin | 13.04 | 10.14 | 9.82 | 7.42 | 4.56 | |||||
Levered Free Cash Flow Margin | 3.58 | 4.82 | 8.88 | -3.93 | -7.34 | |||||
Unlevered Free Cash Flow Margin | 3.66 | 4.97 | 9.29 | -3.5 | -6.92 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.82 | 0.88 | 0.54 | 0.51 | 0.5 | |||||
Fixed Assets Turnover | 5.88 | 6.07 | 2.99 | 2.15 | 1.68 | |||||
Receivables Turnover (Average Receivables) | 3.35 | 4.08 | 3.12 | 3.15 | 2.74 | |||||
Inventory Turnover (Average Inventory) | 4.76 | 4.5 | 2.94 | 3.32 | 3.37 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.06 | 3.1 | 3.2 | 2.78 | 2.09 | |||||
Quick Ratio | 2.5 | 2.42 | 2.61 | 2.2 | 1.53 | |||||
Operating Cash Flow to Current Liabilities | 0.36 | 0.52 | 0.77 | 0.46 | 0.28 | |||||
Days Sales Outstanding (Average Receivables) | 109.11 | 89.52 | 116.97 | 115.87 | 133.74 | |||||
Days Outstanding Inventory (Average Inventory) | 76.85 | 81.03 | 124.25 | 109.99 | 108.5 | |||||
Average Days Payable Outstanding | 95.46 | 86.32 | 120.15 | 92.97 | 99.15 | |||||
Cash Conversion Cycle (Average Days) | 90.5 | 84.23 | 121.07 | 132.89 | 143.08 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 12.29 | 17.82 | 19.02 | 18.35 | 16.03 | |||||
Total Debt / Total Capital | 10.94 | 15.12 | 15.98 | 15.51 | 13.81 | |||||
LT Debt/Equity | 10.76 | 10.81 | 11.52 | 10.1 | 6.01 | |||||
Long-Term Debt / Total Capital | 9.59 | 9.17 | 9.68 | 8.53 | 5.18 | |||||
Total Liabilities / Total Assets | 34.66 | 32.08 | 29.62 | 28.86 | 28.44 | |||||
EBIT / Interest Expense | 177.21 | 69.13 | 19.44 | 17.07 | 10.14 | |||||
EBITDA / Interest Expense | 191.83 | 80.03 | 24.65 | 22.97 | 17.57 | |||||
(EBITDA - Capex) / Interest Expense | 161.64 | 51.44 | 7.12 | 5.14 | -4.69 | |||||
Total Debt / EBITDA | 0.47 | 0.76 | 1.46 | 1.57 | 1.86 | |||||
Net Debt / EBITDA | -1.72 | -1.55 | -2.59 | -1.67 | -0.49 | |||||
Total Debt / (EBITDA - Capex) | 0.56 | 1.18 | 5.07 | 7.02 | -6.97 | |||||
Net Debt / (EBITDA - Capex) | -2.05 | -2.41 | -8.98 | -7.47 | 1.84 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 37.77 | 32.79 | -38.46 | -11.16 | -7.45 | |||||
Gross Profit, 1 Yr. Growth % | 16.53 | 9.82 | -36.19 | -9.63 | -13.97 | |||||
EBITDA, 1 Yr. Growth % | 24.35 | 1.27 | -47.61 | -15.39 | -32.43 | |||||
EBITA, 1 Yr. Growth % | 21.78 | -3.3 | -51.36 | -20.27 | -46.26 | |||||
EBIT, 1 Yr. Growth % | 22.03 | -3.19 | -51.31 | -20.47 | -46.37 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 8.92 | 5.44 | -37.06 | -32.11 | -44.5 | |||||
Net Income, 1 Yr. Growth % | 5.32 | 6.68 | -36.57 | -35.02 | -44.17 | |||||
Normalized Net Income, 1 Yr. Growth % | 4.72 | 3.19 | -40.37 | -34.16 | -43.07 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 5.63 | 6.06 | -35.71 | -35.56 | -43.1 | |||||
Accounts Receivable, 1 Yr. Growth % | 50.37 | -18.74 | -23.11 | 2.54 | 4.85 | |||||
Inventory, 1 Yr. Growth % | 118.24 | 22.56 | -31.05 | -8.62 | -3.83 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 9.98 | 26.09 | 24.23 | 22.75 | 15.53 | |||||
Total Assets, 1 Yr. Growth % | 38.21 | 9.34 | -6.98 | -5.1 | -6.86 | |||||
Tangible Book Value, 1 Yr. Growth % | 16.49 | 12.91 | -4.47 | -8.44 | -8.41 | |||||
Common Equity, 1 Yr. Growth % | 15.84 | 11.85 | -4.04 | -4.63 | -7.7 | |||||
Cash From Operations, 1 Yr. Growth % | 0.04 | 26.44 | 19.61 | -43.31 | -37.44 | |||||
Capital Expenditures, 1 Yr. Growth % | -64.25 | 125.72 | 6.16 | -5.79 | 9.25 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -85.61 | 106.95 | 13.2 | -138.55 | 57.35 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -85.29 | 107.25 | 14.98 | -132.82 | 64.79 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 70.01 | -20 | -42.5 | -6.52 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 38.24 | 35.35 | -9.6 | -26.06 | -9.32 | |||||
Gross Profit, 2 Yr. CAGR % | 22.88 | 13.27 | -16.29 | -24.07 | -11.83 | |||||
EBITDA, 2 Yr. CAGR % | 25.55 | 12.48 | -27.1 | -32.59 | -24.11 | |||||
EBITA, 2 Yr. CAGR % | 23.43 | 8.47 | -31.36 | -36.79 | -34.22 | |||||
EBIT, 2 Yr. CAGR % | 23.52 | 8.53 | -31.34 | -37.06 | -34.69 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 14.68 | 7.15 | -18.53 | -34.63 | -38.61 | |||||
Net Income, 2 Yr. CAGR % | 12.23 | 5.98 | -17.74 | -35.8 | -39.77 | |||||
Normalized Net Income, 2 Yr. CAGR % | 12.09 | 4.04 | -21.56 | -36.76 | -38.78 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 11.49 | 5.71 | -17.43 | -35.64 | -39.45 | |||||
Accounts Receivable, 2 Yr. CAGR % | 59.86 | 10.54 | -20.96 | -11.21 | 3.69 | |||||
Inventory, 2 Yr. CAGR % | 75.04 | 63.55 | -8.07 | -20.62 | -6.26 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 39 | 22.75 | 25.16 | 23.49 | 19.09 | |||||
Total Assets, 2 Yr. CAGR % | 26.08 | 23.85 | 0.85 | -6.01 | -5.99 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.84 | 15.99 | 3.86 | -6.47 | -8.43 | |||||
Common Equity, 2 Yr. CAGR % | 13.67 | 15.11 | 3.6 | -4.33 | -6.18 | |||||
Cash From Operations, 2 Yr. CAGR % | -2.5 | 20.61 | 22.97 | -17.65 | -40.45 | |||||
Capital Expenditures, 2 Yr. CAGR % | -1.07 | -8.46 | 54.8 | 0.01 | 3.05 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -60.43 | -49.21 | 53.06 | -33.26 | -18.35 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -60 | -48.45 | 54.37 | -37.97 | -22.48 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 30.39 | 16.62 | -32.18 | -26.69 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 17.57 | 36.46 | 4.08 | -10.13 | -20.31 | |||||
Gross Profit, 3 Yr. CAGR % | 4.24 | 18.46 | -6.45 | -14.13 | -20.84 | |||||
EBITDA, 3 Yr. CAGR % | 1.78 | 17.05 | -12.76 | -22.75 | -32.37 | |||||
EBITA, 3 Yr. CAGR % | -0.18 | 13.75 | -16.93 | -27.12 | -39.92 | |||||
EBIT, 3 Yr. CAGR % | -0.17 | 13.78 | -16.91 | -27.35 | -40.33 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 2.83 | 11.5 | -10.26 | -23.34 | -38.1 | |||||
Net Income, 3 Yr. CAGR % | 1.37 | 10.34 | -10.69 | -23.96 | -38.72 | |||||
Normalized Net Income, 3 Yr. CAGR % | -0.66 | 9.1 | -13.58 | -25.55 | -38.94 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -4.58 | 9.56 | -10.44 | -23.98 | -38.23 | |||||
Accounts Receivable, 3 Yr. CAGR % | 31.26 | 27.58 | -2.06 | -13.79 | -6.15 | |||||
Inventory, 3 Yr. CAGR % | 48.45 | 55.43 | 22.63 | -8.26 | -15.38 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 56.17 | 38.33 | 23.24 | 24.35 | 20.78 | |||||
Total Assets, 3 Yr. CAGR % | 42.98 | 20.83 | 12.58 | -1.15 | -6.29 | |||||
Tangible Book Value, 3 Yr. CAGR % | 40.5 | 14.39 | 8.73 | -0.41 | -7.12 | |||||
Common Equity, 3 Yr. CAGR % | 42.31 | 13.91 | 8.33 | 0.78 | -5.47 | |||||
Cash From Operations, 3 Yr. CAGR % | -9.48 | 11.4 | 20.28 | -5 | -24.86 | |||||
Capital Expenditures, 3 Yr. CAGR % | 10.85 | 31.88 | -3.83 | 31.18 | 4.07 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -29.92 | -34.53 | -33.66 | -2.68 | -8.33 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -29.46 | -33.88 | -32.65 | -7.27 | -11.01 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.72 | 19.35 | 10.8 | -7.87 | -24.52 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 40.2 | 33.77 | 5.87 | 6.8 | -1.51 | |||||
Gross Profit, 5 Yr. CAGR % | 40.27 | 23.08 | -4.47 | -0.84 | -8.64 | |||||
EBITDA, 5 Yr. CAGR % | 49.11 | 21.84 | -10.86 | -6.1 | -17.08 | |||||
EBITA, 5 Yr. CAGR % | 48.8 | 19.58 | -14.08 | -10.04 | -23.88 | |||||
EBIT, 5 Yr. CAGR % | 48.81 | 19.58 | -14.11 | -10.22 | -24.2 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 45.31 | 20.36 | -6.32 | -9.94 | -22.91 | |||||
Net Income, 5 Yr. CAGR % | 44.13 | 19.66 | -6.76 | -11.15 | -23.71 | |||||
Normalized Net Income, 5 Yr. CAGR % | 43.32 | 17.71 | -9.59 | -12.28 | -24.43 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 39.24 | 15.26 | -9.99 | -11.44 | -23.42 | |||||
Accounts Receivable, 5 Yr. CAGR % | 50.81 | 27.03 | 7.16 | 10.36 | 0.2 | |||||
Inventory, 5 Yr. CAGR % | 56.3 | 39.95 | 22.55 | 18.8 | 10.14 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 54.42 | 57.23 | 45.33 | 32.19 | 21.56 | |||||
Total Assets, 5 Yr. CAGR % | 61.09 | 43.19 | 24.72 | 9.28 | 4.77 | |||||
Tangible Book Value, 5 Yr. CAGR % | 60.45 | 45.58 | 25.07 | 5.54 | 1.51 | |||||
Common Equity, 5 Yr. CAGR % | 62.39 | 45.64 | 25.9 | 6.23 | 2.28 | |||||
Cash From Operations, 5 Yr. CAGR % | 31.67 | 23.28 | 5.23 | -1.29 | -9.2 | |||||
Capital Expenditures, 5 Yr. CAGR % | 36.8 | 38.29 | 27.65 | 18.07 | -1.13 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 131.45 | 27.43 | -6.93 | -34.03 | -27.62 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 150.95 | 28.1 | -6.12 | -35.54 | -28.47 | |||||
Dividend Per Share, 5 Yr. CAGR % | 9.86 | 33.14 | 11.2 | -4.8 | -6.07 |
- Stock Market
- Equities
- 002925 Stock
- Financials Xiamen Intretech Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















